DexCom (DXCM)
(Real Time Quote from BATS)
$115.40 USD
+2.39 (2.12%)
Updated Jul 16, 2024 02:10 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
Brokerage Reports
DexCom, Inc. [DXCM]
Reports for Purchase
Showing records 401 - 413 ( 413 total )
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
THE NEXT PERFECT STORM-OBAMACARE WILL STRETCH THE SYSTEM TO ITS ULTIMATE LIMIT
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Q2 Financials Meet Expectations. SEVEN PLUS Demand Remains Strong and New Product Launches Anticipated.
Provider: WEDBUSH SECURITIES INC.
Analyst: LAU R
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Q2 Preview: We are at the Mid-Range of Consensus and Believe Our Estimates are Achievable.
Provider: WEDBUSH SECURITIES INC.
Analyst: LAU R
Company: DexCom, Inc.
Industry: Medical - Products
70TH ANNUALAMERICAN DIABETES ASSOCIATION MEETING CONFIRMS THESIS - BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: DexCom, Inc.
Industry: Medical - Products
Life Sciences: Biopharmaceuticals / Biotechnology.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L